Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$237.11 - $299.66 $1.96 Million - $2.48 Million
-8,260 Closed
0 $0
Q1 2022

Mar 10, 2023

BUY
$257.27 - $315.76 $2.13 Million - $2.61 Million
8,260 New
8,260 $2.42 Million
Q1 2022

Jul 20, 2022

BUY
$257.27 - $315.76 $1.61 Million - $1.98 Million
6,270 Added 315.08%
8,260 $2.42 Million
Q4 2021

Mar 10, 2023

BUY
$292.08 - $329.01 $233,664 - $263,208
800 Added 67.23%
1,990 $655,000
Q4 2021

Jul 20, 2022

BUY
$292.08 - $329.01 $233,664 - $263,208
800 Added 67.23%
1,990 $656,000
Q2 2021

Mar 10, 2023

BUY
$225.08 - $271.69 $267,845 - $323,311
1,190 New
1,190 $319,000
Q2 2021

Jul 20, 2022

BUY
$225.08 - $271.69 $254,340 - $307,009
1,130 Added 1883.33%
1,190 $319,000
Q4 2020

Jul 20, 2022

BUY
$212.5 - $245.46 $12,750 - $14,727
60 New
60 $13,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Triasima Portfolio Management Inc. Portfolio

Follow Triasima Portfolio Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Triasima Portfolio Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Triasima Portfolio Management Inc. with notifications on news.